| Dr Dana Miller, PHARMD | |
|
570 Pontiac Ave, Cranston, RI 02910-4710 | |
| (850) 718-8319 | |
| Not Available |
| Full Name | Dr Dana Miller |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 570 Pontiac Ave, Cranston, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407346356 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH05682 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dana Miller, PHARMD 90 Sycamore St Unit 1, Providence, RI 02909-1930 Ph: (850) 718-8319 | Dr Dana Miller, PHARMD 570 Pontiac Ave, Cranston, RI 02910-4710 Ph: (850) 718-8319 |
News Archive
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
Policies that helped financially struggling Americans stay in their homes and keep access to water and electricity during the COVID-19 pandemic also helped reduce the spread of the virus, according to a new analysis by Duke University researchers.
A new model developed at MIT can help predict if patients at risk for Alzheimer's disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA™ (belimumab) met the primary endpoint in BLISS-76, the second of two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE). BLISS-76 study results through 52 weeks showed that belimumab 10 mg/kg plus standard of care achieved a statistically significant improvement in patient response rate as measured by the SLE Responder Index at Week 52, compared with placebo plus standard of care.
A New York City health information technology project could provide a model for the implementation of stimulus-funded electronic health records in hospitals and doctors offices around the country, reports Government Health IT, a publication of an e-health lobbying group.
› Verified 7 days ago
Francine Brown, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Cvs Pharmacy, 681 Reservoir Ave, Cranston, RI 02910 Phone: 401-943-7186 | |
Brittany Durgin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1195 Oaklawn Ave, Cranston, RI 02920 Phone: 401-463-1971 | |
Louis Anthony Bergantino Iii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Atwood Ave, Cranston, RI 02920 Phone: 401-944-2669 Fax: 401-944-8506 | |
Tonya Lee Lomastro, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1776 Plainfield Pike, Cranston, RI 02921 Phone: 401-946-2040 | |
Pamela Parente, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 Atwood Ave, Cranston, RI 02920 Phone: 401-942-4100 | |
Dr. Olivia Rossi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1010 Park Ave, Cranston, RI 02910 Phone: 401-946-0337 | |
Justine A Haverinen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1279 Oaklawn Ave, Cranston, RI 02920 Phone: 401-463-8039 |